Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors

Bioorg Med Chem Lett. 2020 Sep 15;30(18):127430. doi: 10.1016/j.bmcl.2020.127430. Epub 2020 Jul 24.

Abstract

A series of inhibitors of the soluble epoxide hydrolase (sEH) containing lipophilic groups of natural origin (camphanyl, norcamphanyl, furan-2-yl) were developed. Inhibitory potency ranging from 0.4 nM to 2.16 μM were obtained. While having the same level of inhibitory activity bicyclic ureas are up to 10-fold more soluble than the corresponding ureas containing adamantyl or 4-trifluoromethoxyphenyl substituents. This makes them easier to formulate, more bioavailable and thus more promising as therapeutic sEH inhibitors. Endo/exo-form of compound 2b derived from l-camphor is 14-fold more potent than the corresponding analogue derived from d-camphor (IC50 = 3.7 nM vs. 50.6 nM) indicating enantiomeric preference.

Keywords: Adamantane; Camphor; Inhibitor; Norcamphane; Soluble epoxide hydrolase; Urea.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantane / chemistry*
  • Adamantane / metabolism
  • Binding Sites
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / metabolism
  • Epoxide Hydrolases / antagonists & inhibitors*
  • Humans
  • Lipids / chemistry*
  • Molecular Docking Simulation
  • Protein Binding
  • Solubility
  • Stereoisomerism
  • Structure-Activity Relationship
  • Urea / analogs & derivatives
  • Urea / chemistry
  • Water

Substances

  • Enzyme Inhibitors
  • Lipids
  • Water
  • Urea
  • Epoxide Hydrolases
  • Adamantane